Skip to main content Scroll Top

News

  • Home
  • Alzheimer
  • Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation
Most Viewed Posts
Clear Filters
REGEnLIFE cures inflammatory brain diseases with light
REGEnLIFE cures inflammatory brain diseases with light
21 February 2025
Designing a unique treatment protocol by assessing efficient photonic and magnetic emission parameters on an Alzheimer’s disease animal model
25 January 2019
Translation from Preclinical Research to Clinical Trials: Brain-Gut Photobiomodulation Therapy for Alzheimer’s Disease
Translation from Preclinical Research to Clinical Trials: Brain-Gut Photobiomodulation Therapy for Alzheimer’s Disease
11 March 2024
1 December 2022

Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation

15th Clinical Trials on Alzheimer’s Disease (CTAD) 2022, San Francisco
Read the article

Julien Delrieu, Aroa Relano-Gines, Patrice Cristofini, Julie Bisiaux, Sara Guillemin, Guillaume Blivet, Jacques Touchon

Share this article

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.